BRS5 - Gut-Brain Axis & Enteric Nervous System
(Gut Barrier, Microbial Signalling & Gut–Brain Neural Pathways)
Ambition
Maintain a resilient gut–brain interface — barrier selective, microbial ecology supportive, and gut-to-brain communication proportionate — so the brain receives stable microbial and neural signals without chronic immune activation or inflammatory spillover.
Therapeutic Area Research
ADHD is the first fully mapped therapeutic area within the BRAIN Framework, providing a proof of concept for an adaptive biological architecture linking nutrition, biology and function. The same framework is designed to expand across additional therapeutic areas through the shared Phenome Registry.
Introduction
Gut–brain axis function in ADHD reflects distributed peripheral regulatory capacities — gut barrier selectivity, microbial turnover, short-chain fatty acid and polyphenol metabolite signalling, vagal communication and gut-side neurotransmitter precursor biotransformation — not disruption of a single microbial pathway.
ADHD translational biological context
ADHD-relevant gut–brain evidence comes from studies conducted in ADHD cohorts or ADHD-labelled intervention trials: reduced microbial alpha diversity in paediatric ADHD Prehn-Kristensen et al., 2018; gut microbiome composition linked to neural reward anticipation in ADHD Aarts et al., 2017; compositional differences in gut microbiota profiles in treatment-naïve children with ADHD Jiang et al., 2018; lower faecal short-chain fatty acid levels in ADHD versus controls Steckler et al., 2024; open-label Bifidobacterium bifidum supplementation with symptom and microbiota changes in children with ADHD Wang et al., 2022; early-life probiotic exposure with later neurodevelopmental risk associations including ADHD in a small randomised trial Pärtty et al., 2015; and ADHD-focused gut microbiota–gut–brain axis review framing Schleupner & Carmichael, 2022. General SCFA, propionate, prebiotic, and vagal mechanistic papers belong on BRS5 architecture pages rather than this ADHD dropdown.
Collectively, these findings do not imply that gut dysbiosis is universal in ADHD, nor that individual microbiome markers define the disorder. Instead, they support interpreting gut–brain axis biology as a modifiable regulatory system through which dietary, lifestyle, and microbial-context interventions may influence cognitive and behavioural function. This translational perspective underpins the BRS5 architecture.
ADHD evidence and connected BRS5 mechanisms
| Evidence | Citation | Connected mechanisms |
|---|---|---|
| Reduced microbial alpha diversity reported in paediatric ADHD cohorts | Prehn-Kristensen et al., 2018 | BRS5(FM2), BRS5-FM2-PM4 |
| Gut microbiome composition linked to neural reward anticipation in ADHD | Aarts et al., 2017 | BRS5-FM1-PM3 |
| Compositional differences in gut microbiota profiles in treatment-naïve children with ADHD, including beneficial taxa guild shifts | Jiang et al., 2018 | BRS5(FM1), BRS5-FM1-PM3 |
| ADHD cohorts showed lower faecal SCFA levels including acetic, propionic, isobutyric, isovaleric, and valeric acids versus controls | Steckler et al., 2024 | BRS5-FM2-PM5, BRS5-FM2-PM4 |
| Open-label Bifidobacterium bifidum supplementation associated with symptom change and altered gut microbiota in children with ADHD | Wang et al., 2022 | BRS5-FM1-PM3, BRS5-FM3-PM7 |
| Early-life Lactobacillus rhamnosus GG exposure with later neurodevelopmental risk associations including ADHD; hypothesis-generating developmental modulation window rather than definitive prevention | Pärtty et al., 2015 | BRS5-FM1-PM3, BRS5(FM3) |
| ADHD-focused review of gut microbiota–gut–brain axis research gaps, including female inclusion in study design | Schleupner & Carmichael, 2022 | BRS5(FM2), BRS5-FM2-PM4 |
Current evidence limitations
| Evidence | Citation | Connected mechanisms |
|---|---|---|
| Human dietary intervention studies directly measuring gut-barrier, SCFA, and vagal functional mechanisms in ADHD remain limited; probiotic and psychobiotic findings show inconsistent taxa directions across cohorts | Future evidence integration | BRS5-wide; especially BRS5(FM1), BRS5(FM2), and BRS5(FM3) |
Framework expansion
- BRS5(SM-Lifestage) — pending: early-life probiotic modulation windows synthesised in Pärtty et al., 2015; dedicated SM-Lifestage pages not yet published.
- Cross-BRS shared evidence: reduced microbiome alpha diversity (Prehn-Kristensen et al., 2018) is routed here for ecological-turnover interpretation and is also represented on BRS3 — Inflammation & Oxidative Stress; immune–allergy overlap in ADHD (Wesselink et al., 2019) is represented on BRS3.
Dietary and Lifestyle Levers
Maintaining a resilient gut–brain interface depends on consistent fermentable-substrate intake, dietary plant diversity, barrier-supportive nutrients and steady meal rhythm rather than isolated probiotic or fibre interventions. Meal quality, eating regularity, sleep and stress recovery collectively shape microbial metabolites, immune regulation and vagal signalling that support stable gut–brain communication.
The following dietary guidance summarises the principal dietary patterns, shared nutrient pools and representative food sources that support the biological constraints underlying BRS5. The guidance reflects shared biological principles rather than prescriptive recommendations; individual requirements and optimal dietary patterns will vary according to physiology, health status and the wider diet.
Pattern → Nutrients → Biology → Target Foods
Key Constraints of BRS5
Fermentable Fibres — KC1: Fermentable Fibre Sufficiency
Include fermentable fibre from legumes, oats, onions and fruit regularly → inulin/GOS and pectin/soluble fibre → microbial fermentation and short-chain fatty acid production depend on these prebiotic substrates; when fermentable fibre is chronically scarce, SCFA signalling and ecological turnover become under-supported.
Target foods: Oats • Lentils • Onions • Apples • Flax Seeds. KC: BRS5(KC1). BRS: BRS5-FM2-PM5 BRS5-FM2-PM4 BRS5-FM1-PM3
Include resistant-starch patterns regularly → resistant starch → cooled starches and legumes supply a distinct fermentable class that supports butyrate-oriented microbial metabolism; relying on one fibre type alone leaves this arm of the shared pool under-covered.
Target foods: Lentils • Potatoes • Rice • Barley • Sweet Potatoes. KC: BRS5(KC1). BRS: BRS5-FM2-PM5 BRS5-FM1-PM1
Polyphenol & Plant-Diversity Inputs — KC2: Polyphenol & Plant-Diversity Input Sufficiency
Include polyphenol-rich plant foods regularly → microbiome-active polyphenols → microbial biotransformation pathways depend on continuous polyphenol input; when plant polyphenols are scarce, gut–brain and mitochondria-linked metabolite generation become under-supported.
Target foods: Blueberries • Green Tea • Cocoa • Pomegranates • Walnuts. KC: BRS5(KC2). BRS: BRS5-FM2-PM6 BRS5-FM1-PM3
Eat a wide variety of plant foods daily → plant-diversity inputs → microbial ecological capacity depends on diverse phytochemical and fibre contexts; reduced plant variety over time may diminish the stability of microbiome-derived signalling relevant to gut–brain communication.
Target foods: Lentils • Barley • Spinach • Oregano • Chickpeas. KC: BRS5(KC2). BRS: BRS5-FM2-PM4 BRS5-FM1-PM3
Barrier-Supportive Nutrients — KC3: Barrier-Supportive Nutrient Sufficiency
Include omega-3-rich whole foods regularly → omega-3 fatty acids → tight-junction integrity and mucosal immune tone at the gut interface depend on adequate long-chain fatty-acid context; low omega-3 status leaves barrier containment under-supported.
Target foods: Salmon • Sardines • Mackerel • Algal Oil • Eggs. KC: BRS5(KC3). BRS: BRS5-FM1-PM1 BRS5-FM1-PM2
Omega-3: Marine foods and algae provide preformed DHA and EPA. Plant ALA sources require endogenous conversion with variable efficiency.
Maintain vitamin A, zinc and glutamine-supportive protein coverage → vitamin A precursors and retinol, zinc and glutamine-supportive amino acids → epithelial renewal and mucosal immune containment need these barrier nutrients; sparse coverage leaves selective gut permeability under-supported.
Target foods: Eggs • Liver • Oysters • Pumpkin Seeds • Chicken. KC: BRS5(KC3). BRS: BRS5-FM1-PM1 BRS5-FM1-PM2
Additional Mechanism-Specific Dietary Levers
Include fermented foods where tolerated → live cultures and postbiotic peptides → may contribute to microbial and postbiotic signalling routes relevant to vagal and enteric nervous system function, though specific food effects remain heterogeneous and context-dependent.
Target foods: Kefir • Greek Yogurt • Kimchi • Sauerkraut • Fermented Vegetables. BRS: BRS5-FM3-PM7 BRS5-FM1-PM3
Favour lower ultra-processed and emulsifier-heavy food patterns → lower avoidable barrier and endotoxin pressure → sustained whole-food patterns matter more than short-term resets; ultra-processed matrices and emulsifier load can strain epithelial containment beyond nutrient insufficiency alone, amplifying gut-derived inflammatory signalling.
Target foods: Oats • Lentils • Eggs • Salmon • Spinach. BRS: BRS5-FM1-PM2 BRS5-FM1-PM1 BRS5-FM2-PM4
Targeted interventions that may enhance biological system performance beyond foundational dietary guidance and lifestyle priorities. They complement — rather than replace — Key Constraints, Dietary Guidance and Lifestyle Priorities.
Optimising food structure, cooking, bioavailability and nutrient delivery.
Prepare fermentable staples and include traditionally fermented foods where tolerated to improve digestibility of fermentable substrates and preserve living or minimally heat-killed matrices that support SCFA production, keystone ecology and barrier signalling.
Supports: BRS5-FM1-PM1 BRS5-FM1-PM2 BRS5-FM1-PM3 BRS5-FM2-PM4 BRS5-FM2-PM5 BRS5-FM3-PM7
Soak legumes and phytate-rich plant foods thoroughly before cooking to improve digestibility and mineral bioavailability while keeping fermentable fibre available for microbial metabolism.
Supports: BRS5-FM1-PM3 BRS5-FM2-PM5 BRS5-FM3-PM7
Pair fat-soluble compounds with dietary fat to support absorption of barrier- and signalling-relevant lipids within mixed meals.
Supports: BRS5-FM1-PM1 BRS5-FM1-PM2 BRS5-FM3-PM8
Evidence-informed supplements used under selected physiological or clinical conditions — populated from KC Emerging Biological Supports when present.
Coming soon
Targeted dietary approaches that modify physiology beyond routine healthy eating.
Coming soon
Practices that support circadian entrainment and biological timing.
Coming soon
Practices that deliberately influence autonomic function, adaptive stress responses and physiological resilience.
Coming soon
Maintain consistent daily meal timing to support microbial rhythm stability, fermentation continuity, and steadier gut–brain signalling over time.
Supports: BRS5-FM1-PM1 BRS5-FM2-PM4 BRS5-FM2-PM5 BRS5-FM3-PM7
Prioritise sleep and manage stress to reduce indirect strain on gut barrier integrity, endotoxin load, and enteric signalling stability.
Supports: BRS5-FM1-PM2 BRS5-FM3-PM7 BRS5-FM3-PM8
Limit alcohol exposure to reduce lifestyle-related barrier strain and support a more stable gut immune and microbial environment.
Supports: BRS5-FM1-PM1 BRS5-FM1-PM2
Functional Mechanisms
Gut barrier integrity, microbial metabolite signalling, and vagal–enteric neuromodulation link the gut interface to brain chemistry, immune tone, and stress responses. These routes determine whether gut-derived signals support or strain neurotransmission, inflammation, and metabolic recovery.
- BRS5-FM1-PM1 — Gut Barrier / Tight Junction Integrity
- BRS5-FM1-PM2 — LPS / Endotoxin Containment
- BRS5-FM1-PM3 — Keystone Taxa Support
Maintains gut-barrier integrity and immune interface stability through tight-junction regulation, mucus protection, and selective immune containment.
FM page: BRS5(FM1) — Gut Barrier Integrity & Immune Interface
Primary biological effects: ↑ tight-junction integrity; ↓ LPS translocation; ↑ gut-immune containment
Modulation context: Intervention: Food-State Dominant · Timing-specific: Yes · Coverage: Daily
Key constraints:
Connected mechanisms:
- BRS3-FM1-PM2 - Gut-Derived Inflammatory Signalling — and wider immune tone
- BRS6-FM1-PM3 - Insulin Sensitivity & Glucose Disposal — biological connection relevant to this mechanism
- BRS5-FM2-PM4 — Microbial Ecological Turnover & Competitive Selection
- BRS5-FM2-PM5 — SCFA Production & Signalling
- BRS5-FM2-PM6 — Polyphenol Biotransformation & Mitochondrial-Relevant Metabolite Generation
Maintains microbial metabolite signalling capacity by supporting production of beneficial metabolites that shape immune, endocrine, and neurobiological pathways.
FM page: BRS5(FM2) — Microbial Metabolite Signalling Capacity
Primary biological effects: ↑ SCFA signalling; ↑ polyphenol biotransformation; ↑ metabolite-mediated gut-brain communication
Modulation context: Intervention: Food-State Dominant · Timing-specific: Yes · Coverage: Daily
Key constraints:
- BRS5(KC1) — Fermentable Fibre Availability
- BRS5(KC2) — Polyphenol & Plant-Diversity Input Availability
Connected mechanisms:
- BRS3-FM1-PM2 - Gut-Derived Inflammatory Signalling — biological connection relevant to this mechanism
- BRS4-FM1-PM1 - Electron Transport Chain Function — biological connection relevant to this mechanism
- BRS6-FM2-PM5 - Circadian Feeding & Light-Dark Entrainment — fM2-PM5 - Circadian Feeding & Light-Dark Entrainment context relevant to this mechanism
- BRS5-FM3-PM7 — Vagal / ENS Signalling Modulation
- BRS5-FM3-PM8 — Neurotransmitter Precursor Biotransformation & Availability
Maintains gut-vagal and enteric neuromodulation capacity through microbial, barrier, and metabolite-driven gut-to-brain signalling.
FM page: BRS5(FM3) — Gut-Vagal Neuromodulation & ENS Signalling
Primary biological effects: ↑ vagal signalling; ↑ ENS-brain communication; ↑ mood/attentional regulation support
Modulation context: Intervention: Food-State Leaning · Timing-specific: Yes · Coverage: Daily
Key constraints:
Connected mechanisms:
- BRS1-FM3-PM6 - Neuronal Membrane DHA Incorporation — biological connection relevant to this mechanism
- BRS6-FM1-PM2 - Glycaemic Variability Regulation — biological connection relevant to this mechanism
Cross-BRS Dependencies
Gut biology extends well beyond digestion. Barrier integrity, microbial metabolite signalling and vagal–enteric traffic continuously reshape immune tone, metabolic inputs and neurochemical regulation. Dysfunction at the gut–brain interface rarely produces an isolated gastrointestinal phenotype — it propagates through neurotransmission, inflammation and stress-axis biology.
- (BRS5 → BRS1) Gut–Vagal Modulation of Neurochemical Signalling
- (BRS5 → BRS3) Gut–Immune Drivers of Inflammatory Tone
- (BRS5 → BRS4) Gut-Metabolic Inputs to Mitochondrial Energetics
- (BRS5 → BRS6) Gut–Vagal Influence on Stress-Axis Regulation
Biological Contribution
Collectively, the Functional Mechanisms within BRS5 maintain adaptive gut–brain interface resilience that enables BRS1 to sustain neurotransmitter regulation under prolonged physiological demand.
Systems Significance
By preserving these gut–brain interface capacities, BRS5 functions as an upstream enabling system, reducing the likelihood that impaired gut-derived signalling or substrate availability progressively constrains neurochemical regulation within BRS1 as peripheral immune or metabolic load accumulates. Maintaining BRS5 therefore complements neurotransmitter precursor and cofactor biology by preserving the biological environment within which resilient neurotransmitter regulation can be sustained, rather than substituting for neurotransmitter regulation itself.
Integrated Regulatory Capacity
Together, the Functional Mechanisms within BRS5 maintain gut barrier integrity, microbial metabolite signalling capacity and gut–vagal neuromodulation required to preserve stable peripheral-to-central signalling during prolonged physiological demand. Rather than acting through a single gut–brain pathway, these integrated capacities collectively regulate how host–microbial signalling shapes the biological environment within which BRS1 sustains neurotransmitter regulation.
Supporting Evidence
Bravo et al., 2011 — Demonstrated that gut microbiota can modulate central neurochemical regulation through vagal signalling pathways — supporting the framework interpretation that impaired gut–brain communication may become a principal constraint on neurotransmitter regulation during sustained peripheral perturbation.
Jaggar et al., 2020 — Synthesised how microbial metabolite and vagal signalling interact with central nervous system function — supporting the interpretation of BRS5 as an upstream enabling system preserving BRS1 adaptive performance during sustained physiological demand.
Biological Contribution
Collectively, the Functional Mechanisms within BRS5 maintain adaptive gut barrier and microbial immune containment that enables BRS3 to sustain proportionate inflammatory tone under prolonged physiological demand.
Systems Significance
By preserving these gut–immune interface capacities, BRS5 functions as an upstream enabling system, reducing the likelihood that gut-derived immune signalling progressively amplifies systemic inflammatory burden within BRS3 as peripheral load accumulates. Maintaining BRS5 therefore complements direct immune-modulatory biology within BRS3 by preserving barrier containment rather than substituting for inflammatory regulation itself.
Integrated Regulatory Capacity
Together, the Functional Mechanisms within BRS5 maintain gut barrier integrity, microbial ecological stability and gut-derived immune signalling containment required to limit inappropriate inflammatory spillover during prolonged physiological demand. Rather than acting through a single barrier mechanism, these integrated capacities collectively regulate how peripheral immune signals shape inflammatory tone within BRS3.
Supporting Evidence
O'Mahony et al., 2015 — Synthesised microbiota–gut–brain communication pathways linking gut ecology to peripheral and central inflammatory biology — supporting the framework interpretation that BRS5 gut–immune signalling shapes BRS3 inflammatory tone.
Slavich & Irwin, 2014 — Established stress-to-inflammation signalling as a systems-level pathway reshaping immune and neuroendocrine biology — supporting the interpretation that gut–immune perturbation can propagate inflammatory burden across BRS3 and connected systems.
Biological Contribution
Collectively, the Functional Mechanisms within BRS5 maintain adaptive microbial metabolite signalling capacity that enables BRS4 to sustain bioenergetic reserve under prolonged physiological demand.
Systems Significance
By preserving these gut-derived metabolic signalling capacities, BRS5 functions as an upstream enabling system, reducing the likelihood that impaired microbial metabolite availability progressively constrains mitochondrial bioenergetic capacity within BRS4 as systemic metabolic load accumulates. Maintaining BRS5 therefore complements substrate and cofactor biology within BRS4 by preserving gut-derived energetic support rather than substituting for mitochondrial regulation itself.
Integrated Regulatory Capacity
Together, the Functional Mechanisms within BRS5 maintain fermentable-fibre-driven microbial ecology, short-chain fatty acid signalling and gut-derived metabolic inputs required to support cellular energy handling during prolonged physiological demand. Rather than acting through a single metabolite, these integrated capacities collectively influence how peripheral metabolic signals shape bioenergetic reserve within BRS4.
Supporting Evidence
Picard et al., 2014 — Linked mitochondrial energy metabolism, glucose handling and stress-related pathophysiology — supporting the framework interpretation that metabolic and neuroendocrine load shapes bioenergetic capacity within BRS4.
Jaggar et al., 2020 — Synthesised microbial metabolite signalling intersecting metabolic and neuroendocrine adaptive regulation — supporting the interpretation of BRS5 as an upstream enabler of BRS4 bioenergetic performance.
Biological Contribution
Collectively, the Functional Mechanisms within BRS5 maintain adaptive gut–vagal neuromodulation and microbial signalling that enables BRS6 to sustain stress-axis responsiveness under prolonged physiological demand.
Systems Significance
By preserving these gut–brain interface capacities, BRS5 functions as an upstream enabling system, reducing the likelihood that impaired vagal or microbial signalling progressively disrupts autonomic and HPA-axis regulation within BRS6 as peripheral load accumulates. Maintaining BRS5 therefore complements neuroendocrine biology within BRS6 by preserving gut-derived modulatory input rather than substituting for stress-axis regulation itself.
Integrated Regulatory Capacity
Together, the Functional Mechanisms within BRS5 maintain gut barrier integrity, microbial metabolite signalling and gut–vagal neuromodulation required to regulate autonomic tone and stress-axis responsiveness during prolonged physiological demand. Rather than acting through a single microbial pathway, these integrated capacities collectively shape how peripheral signals influence neuroendocrine recovery capacity within BRS6.
Supporting Evidence
Bravo et al., 2011 — Demonstrated that gut microbiota modulate HPA-axis stress responses via vagal pathways — supporting the framework interpretation that BRS5 gut–vagal signalling shapes BRS6 stress-axis responsiveness.
Thayer et al., 2012 — Linked autonomic regulatory capacity to stress neurobiology and central nervous system function — supporting the interpretation of vagal–neuroendocrine integration as a BRS5 → BRS6 enabling pathway.
Specific Mechanisms
Specific Mechanisms (SMs) are interpretation layers — context-specific readings of stable BRS5 biology grounded in connected PMs, FMs, and KCs. They provide additional biological context for applying the BRAIN Framework. Current SM categories include SM-SNP (genetic variation), SM-CROSS (multi-BRS interpretive concepts), SM-Male and SM-Female (sex-specific biology), SM-Lifestage (e.g. childhood, pregnancy, older adulthood), and SM-Pattern (e.g. vegan, vegetarian, ketogenic). Functional phenotype interpretation is handled via the Phenome Registry rather than SM-PHEN pages. Individual SMs may be combined to create richer biological profiles and support future precision-nutrition applications.